4-(2-Oxopyrrolidin-1-yl)benzaldehyde

Catalog No. :
ACDPFT804
CAS No. :
36151-45-8
Molecular Formula :
C11H11NO2
Molecular Weight :
189.21

IUPAC Name:4-(2-oxopyrrolidin-1-yl)benzaldehyde

4-(2-Oxopyrrolidin-1-yl)benzaldehyde structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$90.00Login to see priceIn stockInquiry
100mg95%$127.00Login to see priceIn stockInquiry
250mg95%$248.00Login to see priceIn stockInquiry
1g95%$694.00Login to see priceIn stockInquiry
5g95%$2019.00Login to see priceIn stockInquiry
25g95%$5999.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Oxopyrrolidin-1-yl)benzaldehyde
IUPAC Name4-(2-oxopyrrolidin-1-yl)benzaldehyde
MDL No.MFCD00454011
Molecular FormulaC11H11NO2
Molecular Weight189.21
SMILESO=CC1=CC=C(N2C(CCC2)=O)C=C1
InChI KeyVADZUJOCSAESJS-UHFFFAOYSA-N
SynonymTIMTEC-BB SBB009724;4-(2-OXO-PYRROLIDIN-1-YL)-BENZALDEHYDE;4-(2-OXO-1-PYRROLIDINYL)BENZALDEHYDE;AKOS B025010;ASINEX-REAG BAS 00138426;ART-CHEM-BB B025010;4-(2-oxopyrrolidin-1-yl)benzaldehyde(SALTDATA: FREE);Benzaldehyde, 4-(2-oxo-1-pyrrolidinyl)-
CAS No.36151-45-8
PubChem CID2794706

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACDPFT804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGPLR128 route compound structure diagram
    ACGPLR1281122-91-4 In Stock
  4. Then
  5. ACDPFT804 route product structure diagram
    ACDPFT80436151-45-8 In Stock
Inquiry

2. ACDPFT804 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDPFT804 route product structure diagram
    ACDPFT80436151-45-8 In Stock
Inquiry

Comments (0)